BiovaxID(R) Lymphoma Vaccine-Induced T-Cell Immune Responses Complement ... MarketWatch (press release) The results (detailed in Abstract #2707), reported by a Senior Investigator from the NCI, demonstrated that vaccination with BiovaxID active immunotherapy following rituximab combination chemotherapy induced nearly universal immune responses which ... |
